
Procyon Corporation (PCYN)
PCYN Stock Price Chart
Explore Procyon Corporation interactive price chart. Choose custom timeframes to analyze PCYN price movements and trends.
PCYN Company Profile
Discover essential business fundamentals and corporate details for Procyon Corporation (PCYN) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
11 Dec 1996
Employees
19.00
Website
https://procyoncorp.comCEO
Justice W. Anderson
Description
Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems primarily in the United States. The company offers advanced skin and wound care products, including the hydrogel wound dressing products, post op surgical kits, saline wound washes, care lotions, and barrier lotions to promote healing in wound and problematic skin conditions, as well as hand sanitizer under the AMERIGEL brand name. It also provides Bioactive Collagen products in the form of power and matrix under the HELIX3 brand name. In addition, the company offers wound care products, such as calcium alginate, foam, gauze, and hyrdocolloid dressing products; and wound care kits, which include calcium alginate, collagen matrix, collagen powder, foam, and hydrogel wound care kits under the AMERX brand name, as well as compression garment line products under the EXTREMIT-EASE name. It sells its products through distributors to institutional customers, such as hospitals, wound care clinics, nursing homes, home health agencies, physicians, and health care practitioners; and retail customers through direct sales, and internet sales, as well as through independent and retail chain drug stores. The company was incorporated in 1987 and is based in Clearwater, Florida.
PCYN Financial Timeline
Browse a chronological timeline of Procyon Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2023
EPS came in at -$0.03 , while revenue for the quarter reached $1.20M .
Earnings released on 30 Sept 2023
EPS came in at -$0.00 , while revenue for the quarter reached $1.17M .
Earnings released on 31 Mar 2023
EPS came in at -$0.00 , while revenue for the quarter reached $1.12M .
Earnings released on 31 Dec 2022
EPS came in at -$0.00 , while revenue for the quarter reached $1.18M .
PCYN Stock Performance
Access detailed PCYN performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.